Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

27,666 signal articles · 231 in last 24h · 134,070 total before filter · latest 44m ago
231last 24h
1112last 7d
180● bullish (7d)
134● bearish (7d)
208publishers
AllMacro295Earnings375M&A73Regulatory28Product10Analyst15
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Visa (V) Broadens Stablecoin Settlement Capabilities
Simply Wall St.22d agoneutral
Visa (V) Broadens Stablecoin Settlement Capabilities

Visa (NYSE:V) is expanding its stablecoin settlement capabilities through new partnerships with Lightspark and Zerohash. The partnerships focus on using USDC and other stablecoins for settlement and payout solutions across Visa's client and partner network. Visa aims to support programmable payments, faster cross-border transactions, and onchain disbursements through these integrations. The move deepens Visa's role in blockchain-based financial infrastructure and supports wider adoption of...

Ares Management (ARES) Earnings And Dividends Put Fair Value Back In Focus
Simply Wall St.22d agoneutral
Ares Management (ARES) Earnings And Dividends Put Fair Value Back In Focus

Ares Management (ARES) shares reacted after the company reported second quarter 2026 results, including revenue of US$1,428.61m and net income of US$150.64m. Management also affirmed quarterly dividends on both common and preferred stock. See our latest analysis for Ares Management. The earnings and dividend announcements appear to have contributed to a sharp short term rebound for Ares Management, with a 30 day share price return of 17.49% and a 90 day gain of 16.18%. However, the year to...

Bechtle Q2 Earnings Call Highlights
MarketBeat22d agoneutral
Bechtle Q2 Earnings Call Highlights

Bechtle (ETR:BC8) reported double-digit growth across most key metrics in the second quarter and first half of 2026, prompting the IT services provider to raise its full-year outlook despite what management described as continued challenging market conditions. Chief Executive Officer Thomas Olemotz

Will Watson Explosion Verdict Shape 3M's (MMM) Litigation Risk and Contingency Planning Narrative?
Simply Wall St.22d agoneutral
Will Watson Explosion Verdict Shape 3M's (MMM) Litigation Risk and Contingency Planning Narrative?

A Harris County jury recently ordered 3M to pay US$61.5 million to Houston homeowners affected by the January 24, 2020 Watson Grinding & Manufacturing explosion, the third bellwether trial in multi-district litigation over the disaster. The verdict highlights how allegations around 3M’s servicing of gas detection and alarm systems could shape ongoing liability exposure for more than 2,000 remaining plaintiffs. We’ll now examine how this latest US$61.5 million verdict and ongoing...

Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed?
Simply Wall St.22d agoneutral
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed?

Absci Corporation recently reported second-quarter 2026 results showing a net loss of US$33.21 million, wider than a year ago, while basic and diluted loss per share from continuing operations narrowed to US$0.21. Alongside these figures, Absci highlighted encouraging early Phase 1 data for ABS-201, its prolactin receptor antibody, and a US$40 million investment and development support from Eli Lilly that extend its cash runway into the second half of 2028. Next, we’ll examine how Eli...

West (WST) Stock Looks Overvalued After A 47% One Year Run
Simply Wall St.22d agoneutral
West (WST) Stock Looks Overvalued After A 47% One Year Run

West Pharmaceutical Services has delivered a strong 46.9% share price return over the past year, and the stock now sits in a zone where its intrinsic value estimate looks roughly in line with the market while several valuation checks flag a richer pricing backdrop. Over the last 12 months, West Pharmaceutical Services has returned 46.9%, which puts extra focus on whether that gain already reflects most of the company’s fundamental strengths. Following recent earnings updates that highlighted...

AbCellera Biologics (ABCL) Is Up 60.3% After Strong Phase 2 Menopause Data For ABCL635 - Has The Bull Case Changed?
Simply Wall St.22d agoneutral
AbCellera Biologics (ABCL) Is Up 60.3% After Strong Phase 2 Menopause Data For ABCL635 - Has The Bull Case Changed?

AbCellera Biologics recently reported that its investigational antibody ABCL635 achieved statistically significant Phase 2 results, with a single 600 mg subcutaneous dose reducing both the frequency and severity of moderate-to-severe menopausal hot flashes versus placebo while showing a favorable tolerability profile over four weeks. By pairing these data with improvements in sleep and patient-reported outcomes, ABCL635 positions AbCellera as an emerging player in the large, under-served...

CoreWeave Cashes in on the AI Gold Rush With a 25% Price Hike, and Customers are Still Lining Up: Vera Rubin Demand is 'Enormous'
Benzinga22d agoneutral
CoreWeave Cashes in on the AI Gold Rush With a 25% Price Hike, and Customers are Still Lining Up: Vera Rubin Demand is 'Enormous'

CoreWeave Inc. (NASDAQ:CRWV) raised prices across its artificial intelligence computing offerings in July and is passing along rising hardware costs to customers, as demand continues to accelerate. A Quarter of Pricing Power CFO Nitin Agrawal told analysts on Tuesday’s earnings call that the increase was “an approximately 25% increase across SKUs in response to the current demand environment.” He added that CoreWeave is separately passing through rising component costs to customers, including pr

Sea (SE) Stock Could Trade At A Premium Despite A 224% Run
Simply Wall St.22d agoneutral
Sea (SE) Stock Could Trade At A Premium Despite A 224% Run

Sea stock has more than tripled over the past three years, yet the current valuation picture is mixed as a Discounted Cash Flow (DCF) estimate points to meaningful upside while market multiples lean expensive and the broader checks are cautious. Sea has returned 224.1% over the last three years, which puts extra focus on whether the current price still offers a margin of safety for new money. Recent strength across e commerce and digital financial services can support expectations for future...

Nutrien (TSX:NTR) Could Be 16% Undervalued After Mixed Quarter And Higher Potash Outlook
Simply Wall St.22d agoneutral
Nutrien (TSX:NTR) Could Be 16% Undervalued After Mixed Quarter And Higher Potash Outlook

Nutrien’s mixed quarter and updated outlook Nutrien (TSX:NTR) reported second quarter sales that were higher than expected, supported by stronger potash prices even as volumes declined and some input costs increased, while adjusted earnings per share came in below analyst expectations. See our latest analysis for Nutrien. The share price of Nutrien has moved to CA$93.60, with a 1-day share price return of 1.32% and a year to date share price return of 7.85%. The 1-year total shareholder...

3 Stocks Under $10 with Questionable Fundamentals
StockStory22d agoneutral
3 Stocks Under $10 with Questionable Fundamentals

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.

Bloomberg22d agoneutral
Norway $2.3 Trillion Fund Posts Best Quarter Since 2020

(Bloomberg) -- Norway’s sovereign wealth fund, the world’s largest, reported its best quarterly return in six years, helped by gains from its large holdings in global technology companies.Most Read from BloombergFive Takeaways From Zuckerberg’s 6,500-Word Manifesto on AIPhoebe Gates Knew Phia Shopping App Took Credit for Sales It Didn’t DrivePakistan Says Deal Is Close Even as Iran, US Harden StancesApple’s Glass-Centric 20th-Anniversary iPhone Remains on Track for 2027Air India Pilot Tests Posi

2 Financials Stocks on Our Buy List and 1 We Find Risky
StockStory22d agobullish
2 Financials Stocks on Our Buy List and 1 We Find Risky

Financial providers use their expertise in capital allocation and risk assessment to help facilitate economic growth while offering consumers and businesses essential financial services. But uncertainty about fiscal and monetary policy has tempered enthusiasm, limiting the industry’s gains to 7.5% over the past six months. This return lagged the S&P 500’s 11% climb.

Foxconn posts quarterly profit surge on AI server demand
AFP22d agobullish
Foxconn posts quarterly profit surge on AI server demand

Taiwanese tech hardware titan Foxconn reported on Wednesday a forecast-busting second quarter net profit, as exploding demand for artificial intelligence servers needed in data centres powered the company's growth.This has turbocharged business for Foxconn, which makes the servers used in the data centres. tpj/amj/fox

3 Reasons to Avoid ON and 1 Stock to Buy Instead
StockStory22d agobullish
3 Reasons to Avoid ON and 1 Stock to Buy Instead

Over the past six months, onsemi has been a great trade, beating the S&P 500 by 9.6%. Its stock price has climbed to $81.31, representing a healthy 20.7% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.